Industry overview
The Manufacture of basic pharmaceutical products and pharmaceutical preparations sector across France comprises approximately 242 enterprises employing about 96,414 people and generating €42.8 bn in net turnover in 2020. The average enterprise size is – employees per firm. This is a useful yardstick when assessing whether your own operation sits within the typical scale band of the sector.
Profitability
With a healthy operating margin of 10.3% of revenue in 2020, the sector reports €4.4 bn of gross operating surplus (Eurostat's EBITDA-equivalent, before depreciation). This figure provides the headline benchmark against which an individual operator can sanity-check their own bottom line, values significantly below indicate cost or pricing pressure, those above suggest competitive advantage worth defending.
Cost structure
The Manufacture of basic pharmaceutical products and pharmaceutical preparations cost mix is reasonably balanced: cost of revenue at 63.2%, personnel at 19.6% and energy at – of turnover. Without a single dominant cost driver, margin management requires attention across the full operating envelope rather than focus on any one line.
Trend & trajectory
Over the period 2008 to 2020 the operating margin moved from 10.7% to 10.3% (-0.4 percentage points), broadly stable performance. Sectors with stable or improving margins tend to reflect successful pass-through of input costs and disciplined capacity management; declining margins typically point to either over-supply or a structural cost squeeze that warrants strategic review.